Abstract
Our previous intravenous, double-blind, placebo-controlled trial of recombinant tissue plasminogen activator (rt-PA) [1] and other intravenous rt-PA trials [2–4] indicated that systemic administration of rt-PA was safe and effective in treating acute carotid artery territory embolic stroke. However, the recanalization efficacy demonstrated in those trials [1–4] was limited; recanalization frequency was at most 50%. Local intraarterial infusion is assumed to be safer and more effective than intravenous infusion by reduction of systemic side effects and increase of recanalization. To examine this assumption, we conducted an intraarterial rt-PA trial. We report here an interim analysis of our ongoing intracarotid trial, and the results are compared with those in our intravenous trial [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976–982
del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Albert MJ, Zivin J, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kace CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86
von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery occlusion. Stroke 23: 646–652
Yamaguchi T, Hayakawa T, Kikuchi H, for the Japanese Thrombolysis Study Group (1993) Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double-blind trial. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg New York, pp 59–65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Tokyo
About this paper
Cite this paper
Yoneda, Y., Mori, E. (1995). Intracarotid Recombinant Tissue Plasminogen Activator in Acute Carotid Artery Territory Stroke. In: Yamaguchi, T., Mori, E., Minematsu, K., del Zoppo, G.J. (eds) Thrombolytic Therapy in Acute Ischemic Stroke III. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68459-6_41
Download citation
DOI: https://doi.org/10.1007/978-4-431-68459-6_41
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70139-2
Online ISBN: 978-4-431-68459-6
eBook Packages: Springer Book Archive